版本:
中国

BRIEF-Intellia Therapeutics and San Raffaele University and Research Hospital to combine CRISPR/cas9 genome editing with enhanced cell therapies

June 6 Intellia Therapeutics Inc

* Intellia Therapeutics and San Raffaele University And Research Hospital to combine CRISPR/cas9 genome editing with enhanced cell therapies to fight cancer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐